
September 18, 2023
RegMed Investors (RMi) Closing Bell: sector stumbles lower
September 18, 2023
RegMed Investors’ (RMi) pre-open: who has a share pricing compass or even a barometer?
September 15, 2023
RegMed Investors (RMi) Closing Bell: a volatile week ending on a triple-witching Friday
September 15, 2023
RegMed Investors’ (RMi) pre-open: understanding perception
September 14, 2023
RegMed Investors (RMi) Closing Bell: rebound
September 14, 2023
RegMed Investors’ (RMi) pre-open: the known unknowns
September 13, 2023
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector runs out of gas
September 13, 2023
RegMed Investors’ (RMi) pre-open: try catching fog in a glass
September 12, 2023
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector resembles my slinky
September 12, 2023
RegMed Investors’ (RMi) pre-open: show me the money
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors